One-dose Sputnik Light vaccine.
The RDIF, which helped finance the vaccine, said Sputnik Light “demonstrated 79.4 percent efficacy” compared to 91.6 percent for the two-shot Sputnik V.
- AFP Moscow
- Last Updated:May 06, 2021, 18:00 IST
- FOLLOW US ON:
Health officials in Russia approved a single-dose version of the Sputnik V coronavirus vaccine, the developers of the shot said Thursday.
The Russian Direct Investment Fund (RDIF), which helped finance the vaccine, said in a statement that Sputnik Light “demonstrated 79.4 percent efficacy” compared to 91.6 percent for the two-shot Sputnik V.
The results, it said, were drawn from “data taken from 28 days after the injection was administered as part of Russia’s mass vaccination program between 5 December 2020 and 15 April 2021″. The Russian vaccine has been approved for use in over 60 countries.
But it has not yet been approved by the European Medicines Agency (EMA) or the United States’ Food and Drug Administration (FDA).
Some Western…